PRECIL Series

PRECIL Series

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Coagulation Testing for Bleeding and Thrombotic Disorders:

• Primary Use: The PRECIL Series coagulation analyzers measure prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen levels, and thrombin time (TT) to diagnose and monitor bleeding disorders (hemophilia, von Willebrand disease) and thrombotic conditions, guiding anticoagulant therapy and preoperative risk assessment.

• How it helps: Provides patients with unexplained bleeding or bruising the answers they need, identifying clotting problems that can range from mild nuisances to life-threatening conditions, and guiding treatment that can prevent bleeding crises.

2. Blood Viscosity and Hemorheology Assessment:

• Primary Use: Specialized hemorheology analyzers in the PRECIL Series measure whole blood viscosity, plasma viscosity, and erythrocyte aggregation and deformability, providing critical information for evaluating hyperviscosity syndromes, sickle cell disease, diabetes, cardiovascular disorders, and other conditions affecting blood flow dynamics.

• How it helps: Reveals how thick or “sticky” a patient’s blood is, helping diagnose conditions where blood flows too slowly through tiny vessels, potentially causing organ damage from poor circulation.

3. Anticoagulant Therapy Monitoring:

• Primary Use: Serial coagulation testing enables monitoring of patients on oral anticoagulants (warfarin), heparin, and direct oral anticoagulants (DOACs), ensuring therapeutic levels while minimizing bleeding risk.

• How it helps: Acts as a safety guardian for patients on blood thinners, giving doctors the precise information they need to adjust doses so the medication is strong enough to prevent dangerous clots but not so strong that it causes life-threatening bleeding.

4. Liver Function Assessment:

• Primary Use: Coagulation tests (particularly PT) are essential for evaluating synthetic liver function in patients with cirrhosis, hepatitis, and acute liver failure, as prolonged PT indicates impaired clotting factor production.

• How it helps: Provides doctors with a crucial window into liver health, helping them detect liver damage and monitor disease progression in patients with hepatitis, cirrhosis, or other liver conditions.

5. Preoperative Bleeding Risk Evaluation:

• Primary Use: Routine coagulation screening before surgical procedures helps identify patients with undiagnosed bleeding disorders or anticoagulant effects, reducing perioperative bleeding complications.

• How it helps: Prevents surgical disasters by catching hidden bleeding risks before the first incision, allowing the surgical team to take precautions and ensuring patients can undergo procedures safely.

6. Disseminated Intravascular Coagulation (DIC) Diagnosis:

• Primary Use: Coagulation analyzer results (prolonged PT/APTT, low fibrinogen, elevated D-dimer) contribute to diagnosing DIC in critically ill patients with sepsis, trauma, or obstetric complications.

• How it helps: Helps critical care teams identify this life-threatening condition where the body’s clotting system goes haywire, consuming all available clotting factors and leading to both massive bleeding and dangerous clots throughout the body.

7. Thrombophilia Workup:

• Primary Use: Specialized coagulation assays help evaluate patients with recurrent thrombosis for inherited or acquired thrombophilia, guiding long-term anticoagulation decisions.

• How it helps: Gives patients who suffer from repeated blood clots answers about why their blood clots too easily, guiding treatment that can prevent future, potentially fatal clots.

SECONDARY & SUPPORTIVE USES

1. Research and Clinical Trials: Used in studies investigating coagulation disorders, hemorheology, and new anticoagulant therapies, contributing to scientific understanding and better treatments.

2. Quality Control in Blood Banking: Coagulation testing for component therapy and fresh frozen plasma quality assessment, ensuring blood products are safe and effective for transfusion.

3. Monitoring in Pregnancy: Coagulation testing for pregnant women with thrombophilia, preeclampsia, or recurrent pregnancy loss, protecting both mother and baby during pregnancy.

4. Neonatal Coagulation Assessment: Specialized low-volume testing for neonates with bleeding or thrombotic concerns, extending advanced diagnostic capability to the smallest patients.

5. Veterinary Medicine: Adapted for coagulation testing in animals with bleeding disorders or undergoing surgery, helping veterinarians provide better care to animal patients.

6. Teaching and Training: Used in medical laboratory science education for coagulation and hemorheology training, building the skills of future laboratory professionals.

7. Epidemiological Studies: Coagulation and viscosity testing in population studies of cardiovascular and thrombotic disease risk, contributing to public health knowledge.